Clinical Trials Logo

Diabetic Neuropathic Pain clinical trials

View clinical trials related to Diabetic Neuropathic Pain.

Filter by:

NCT ID: NCT02783469 Completed - Clinical trials for Diabetic Neuropathic Pain

Genetics of Diabetes Audit and Research in Tayside Scotland (DOLORisk Dundee)

GoDARTS
Start date: October 2004
Phase:
Study type: Observational

In 1997, the global prevalence of diabetes was estimated to be 125 million and this has risen to around 400 million in 2015. In addition diabetes has a number of complications including heart disease, blindness, kidney failure and amputation. This represents a significant burden on healthcare services. Type 2 diabetes (T2D) is caused by a combination of genetic and environmental factors. The aim of GoDARTS is to recruit participants with T2D to a registry to provide a platform with which to investigate the genetics of T2D, its complications and response to treatment. This study will investigate the genetic basis of diabetic neuropathic pain.

NCT ID: NCT01589432 Completed - Clinical trials for Diabetic Neuropathic Pain

A Randomized, Double-blind, Placebo- and Active-controlled Study of the Electric Current Effects of ABT-639 on the Spontaneous Activity of Pain Sensory Receptors in Patients With Diabetic Peripheral Neuropathy

Start date: April 2012
Phase: Phase 2
Study type: Interventional

People with diabetes can, over time develop nerve damage throughout the body with symptoms such as pain, tingling, or numbness (loss of feeling) in the hands, arms, feet and legs.

NCT ID: NCT01579279 Terminated - Clinical trials for Diabetic Neuropathic Pain

A Study Comparing the Efficacy and Safety of ABT-652 to Placebo in Subjects With Diabetic Neuropathic Pain

Start date: April 2012
Phase: Phase 2
Study type: Interventional

To evaluate the safety and efficacy of ABT-652 compared to Placebo in subjects with diabetic neuropathic pain. People with diabetes can, over time develop nerve damage throughout the body with symptoms such as pain, tingling, or numbness (loss of feeling) in the hands, arms, feet and legs.

NCT ID: NCT01345045 Completed - Clinical trials for Diabetic Neuropathic Pain

A Multicenter Study Comparing the Analgesic Effects and Safety of ABT-639 Compared to Placebo in Subjects With Diabetic Neuropathic Pain

Start date: April 2011
Phase: Phase 2
Study type: Interventional

People with diabetes can, over time develop nerve damage throughout the body with symptoms such as pain, tingling, or numbness (loss of feeling) in the hands, arms, feet and legs.

NCT ID: NCT00619983 Terminated - Clinical trials for Chronic Low Back Pain

Three Way Interaction Between Gabapentin, Duloxetine, and Donepezil in Patients With Diabetic Neuropathy

Start date: February 2008
Phase: Phase 4
Study type: Interventional

The purpose of the study is to determine whether the combination of the the three drugs gabapentin, duloxetine, and donepezil are effective in treating pain in people with diabetic neuropathy or patients with failed low back syndrome (chronic back pain).

NCT ID: NCT00548925 Completed - Clinical trials for Diabetic Neuropathic Pain

A Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain

Start date: November 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of a 6 mg twice a day dose of an investigational product in subjects with diabetic neuropathy

NCT ID: NCT00452777 Completed - Clinical trials for Diabetic Neuropathic Pain

Efficacy and Tolerability of Novel A2A Agonist in Treatment of Diabetic Neuropathic Pain

Start date: May 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and tolerability of BVT.115959 in diabetic patients with neuropathic pain who are either not on analgesia or are on stable analgesia in the month prior to entering the study.